Fecal transplant for tough lung infections on a ventilator
Part of Infections clinical trials.
This study tests whether a treatment called fecal microbiota transplantation (FMT) can help clear stubborn lung infections (MDRO) in people who are in the ICU on a ventilator. The goal is to see if FMT can improve recovery and reduce the risk of further organ problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You are in the ICU and on a breathing machine (ventilator) because of a lung or other infection with a resistant bacteria (MDRO).
- Your doctor expects you to need intensive care for at least 7 more days.
- You do not have severe active bleeding or a hole in your stomach or intestines.
- You have not taken strong immune-suppressing drugs (like high-dose steroids for weeks, or certain chemotherapies) in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a fecal microbiota transplant (FMT)—transferring healthy gut bacteria from a donor to your digestive system—can help critically ill patients tolerate food and nutrition delivered through a feeding tube. The goal is to restore gut function and improve recovery in the ICU.
This trial tests whether transplanting healthy donor stool into the lungs can help treat a severe pneumonia caused by a bacteria that is resistant to many antibiotics. It may offer a new option for people whose infection is not responding to standard treatments.
This trial tests if a fecal microbiota transplant (FMT) can improve survival and recovery in ICU patients with sepsis. FMT involves transferring healthy donor bacteria into your gut to help fight severe infection.
This trial tests whether a stool (fecal) transplant from a screened donor can help remove antibiotic-resistant gut bacteria (MDRO) that keep coming back in your stool tests. It aims to reduce colonization that makes follow-up and treatment harder.
This study tests if transferring healthy gut bacteria (fecal microbiota transplant) can help people with acute lung injury caused by sepsis. It aims to reduce inflammation and improve breathing.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
Hear when a new Lung Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.